Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy

Thrombosis and Haemostasis

Volumn 103, Issue 5, 2010, Pages 875-876

  Peter, Karlheinz ^a   Lip, Gregory Y H ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HOMOCYSTEINE; ANTICOAGULANT AGENT; OCRIPLASMIN; PEPTIDE FRAGMENT; PLASMIN;

CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; EDITORIAL; HEART MUSCLE INJURY; HEART VENTRICLE FUNCTION; HEMOSTASIS; HUMAN; LUNG EMBOLISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STROKE; THROMBOSIS; VON WILLEBRAND DISEASE; AGE; ANGIOPLASTY; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL (TOPIC); COMPLICATION; DRUG COMBINATION; HEART ASSIST DEVICE; HEMORRHAGE; IMMUNOLOGY; INFLAMMATION; RISK FACTOR;

AGE FACTORS; ANGIOPLASTY; ANIMALS; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; FIBRINOLYSIN; HEART-ASSIST DEVICES; HEMORRHAGE; HOMOCYSTEINE; HUMANS; INFLAMMATION; PEPTIDE FRAGMENTS; RISK FACTORS; THROMBOSIS;

EID: 77952073948     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-03-0205     Document Type: Editorial

References (8)

1. Schroecksnadel K, Grammer TB, Boehm BO, et al. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemost 2010; 103: 926-935.
2. Di Minno MND, Tremoli E, Di Minno G. Homocysteine and arterial thrombosis: challenge and opportunity. Thromb Haemost 2010; 103: 942-961.
3. Loeffler C, Straub A, Bassler N, et al. Evaluation of platelet activation in patients supported by the Jarvik 2000* high-rotational speed impeller ventricular assist device. J Thorac Cardiovasc Surg 2009; 137: 736-741.
4. Heilmann C, Geisen U, Nakamura L, et al. Acquired von Willebrand syndrome in patients wiht ventricular assist devide or total artificial heart. Thromb Haemost 2010; 103: 962-967.
5. Lankeit M, Konstantinides S. Thrombolysis for pulmonary embolism: Past, present and future. Thromb Haemost 2010; 103: 877-883.
6. Burggraf D, Vosko MR, Schubert, M. Different therapy options protecting microvasculature after experimental cerebral ischemia and reperfusion. Thromb Haemost 2010; 103: 891-900.
7. Harmsze AM, Robijins K, von Werkum JW et al. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers in associated with clopidogrel poor-response. Thromb Haemost 2010; 103: 920-925.
8. Van Walderveen MC, Berry LR, Atkinson HM, et al. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va. Thromb Haemost 2010; 103: 910-919.